Optimization of 2-phenylcyclopropylmethylamines as selective serotonin 2C receptor agonists and their evaluation as potential antipsychotic agents
Access Status
Authors
Date
2015Type
Metadata
Show full item recordCitation
Source Title
ISSN
School
Collection
Abstract
The discovery of a new series of compounds that are potent, selective 5-HT2C receptor agonists is described herein as we continue our efforts to optimize the 2-phenylcyclopropylmethylamine scaffold. Modifications focused on the alkoxyl substituent present on the aromatic ring led to the identification of improved ligands with better potency at the 5-HT2C receptor and excellent selectivity against the 5-HT2A and 5-HT2B receptors. ADMET studies coupled with a behavioral test using the amphetamine-induced hyperactivity model identified four compounds possessing drug-like profiles and having antipsychotic properties. Compound (+)-16b, which displayed an EC50 of 4.2 nM at 5-HT2C, no activity at 5-HT2B, and an 89-fold selectivity against 5-HT2A, is one of the most potent and selective 5-HT2C agonists reported to date. The likely binding mode of this series of compounds to the 5-HT2C receptor was also investigated in a modeling study, using optimized models incorporating the structures of β2-adrenergic receptor and 5-HT2B receptor.
Related items
Showing items related by title, author, creator and subject.
-
Clark, J.; Alves, S.; Gundlah, C.; Rocha, B.; Birzin, E.; Cai, S.; Flick, R.; Hayes, E.; Ho, K.; Warrier, Sudha; Pai, L.; Yudkovitz, J.; Fleischer, R.; Colwell, L.; Li, S.; Wilkinson, H.; Schaeffer, J.; Wilkening, R.; Mattingly, E.; Hammond, M.; Rohrer, S. (2012)Estrogen acts through two molecularly distinct receptors termed estrogen receptor alpha (ERa) and estrogen receptor beta (ERß) which bind estradiol with similar affinities and mediate the effects of estrogen throughout ...
-
Cheong, S.; Dolzhenko, A.; Kachler, S.; Paoletta, S.; Federico, S.; Cacciari, B.; Dolzhenko, Anton; Klotz, K.; Moro, S.; Spalluto, G.; Pastorin, G. (2010)Among the heterocyclic structures identified as potent human A3 (hA3) adenosine receptor’s antagonists, we have demonstrated that the new pyrazolo-triazolo-pyrimidines, bearing an aryl group in replacement of the C2-furyl ...
-
Shi, Y.; Duan, Y.; Ji, Y.; Wang, Z.; Wu, Y.; Gunosewoyo, Hendra; Xie, X.; Chen, J.; Yang, F.; Li, J.; Tang, J.; Xie, X.; Yu, L. (2017)Selective CB 2 agonists represent an attractive therapeutic strategy for the treatment of a variety of diseases without psychiatric side effects mediated by the CB 1 receptor. We carried out a rational optimization of ...